Reduction in viral load observed: ICMR

Head of Epidemiology and Communicable diseases at Indian Council of Medical Research (ICMR) R Gangakhedkar said Saturday that a reduction in the viral load was observed in COVID-19 patients who were administered Hydroxychloroquine drug.

“No research on developing a vaccine for COVID-19 has reached the human trial stage anywhere in the world. All patients having severe acute respiratory illness are being tested for COVID-19,” said Gangakhedkar at the daily briefing here.

Show comments